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COVID-19 Outbreak and Surgical Practice
Unexpected Fatality in Perioperative Period
Ali Aminian, MD,Y Saeed Safari, MD,y Abdolali Razeghian-Jahromi, MD,z
Mohammad Ghorbani, MD,y and Conor P. Delaney, MD§
Little is known about surgical practice in the initial phase of coronavirus
disease 2019 (COVID-19) global crisis. This is a retrospective case series of 4
surgical patients (cholecystectomy, hernia repair, gastric bypass, and hyster-
ectomy) who developed perioperative complications in the first few weeks of
COVID-19 outbreak in Tehran, Iran in the month of February 2020. COVID-
19 can complicate the perioperative course with diagnostic challenge and a
high potential fatality rate. In locations with widespread infections and limited
resources, the risk of elective surgical procedures for index patient and
community may outweigh the benefit.
(Ann Surg 2020;272:e27–e29)
T he global incidence of novel coronavirus disease 2019 (COVID-19) that involves the lower respiratory tract (pneumonia) con-
tinues to rise since December 2019. The disease is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that simul-
taneously has high transmission and fatality rates. Little is known about
surgical practice in the initial phase of the COVID-19 pandemic. The
aim of this report is to describe the clinical presentation and outcomes
of elective surgical patients during the COVID-19 outbreak.
This is a retrospective case series of 4 patients who developed
perioperative complications in the first few weeks of the COVID-19
outbreak in Iran in the month of February 2020. The first case of
COVID-19 in Iran, the epicenter of infection in the Middle East, was
officially reported on February 19, 2020 from the city of Qom.
Three patients developed postoperative fever and pulmonary
complications after uneventful elective operations. Two operations
were performed before the official announcement of outbreak in Iran.
Correct diagnosis and management in the postoperative setting were
challenging. Two patients died (Table 1, Fig. 1).
The fourth case was a patient with severe obesity from Qom
who had been scheduled for bariatric surgery on February 22. One
day before the scheduled surgery he was taken to the emergency
department with severe acute respiratory distress which rapidly
progressed to cardiopulmonary arrest (Table 1).
This case series shows the challenges facing surgical practice
in the initial phase of COVID-19 outbreak. The effects of surgical
and anesthesia stress, perioperative medications, and postoperative
changes (eg, development of lung atelectasis) on predisposition to
new COVID-19 infection or exacerbation of current infection are not
known. Based on current evidence, while it is believed that the
fatality of COVID-19 is between 1 and 3%, most fatalities have
occurred in elderly patients with underlying cardiopulmonary con-
ditions, diabetes, and obesity.1–3 Although the current series may
bias reporting toward more severe outcomes, postoperative patients
may be another group of COVID-19 patients who would have poor
outcomes. A complicated postoperative course may especially be
seen more in elderly patients with underlying health conditions.
In the postoperative period, development of fever or pulmo-
nary complications can lead to a diagnostic challenges and can
complicate the recovery of patients from elective surgery. In patients
with postoperative fever, several diagnostic tests are usually neces-
sary to determine the source. Other forms of infectious pneumonia,
aspiration pneumonia, pulmonary embolism, pulmonary edema, and
other conditions are among the differential diagnoses in patients with
postoperative pulmonary symptoms. During the current progressive
outbreak, a high index of suspicion for COVID-19 may be increas-
ingly important to make a correct diagnosis and to take correct
actions to treat the index patient and to prevent the spread of virus.
The diagnostic accuracy of RT-PCR in the postoperative setting
needs to be determined. Notably, in a recent series from China of over
1000 patients to assess the diagnostic accuracy of different tests, chest
CT scan had sensitivity of 98% compared with RT-PCR sensitivity of
only 71%.4 Furthermore, identification of biomarkers and develop-
ment of clinical prediction models that predict severity and outcomes
of COVID-19 in postoperative period would be extremely helpful.
Some preliminary data suggest that severe lymphopenia and elevated
levels of C-reactive protein (CRP), interleukin-6, cardiac troponin I,
and D-dimer correlate with the severity of hypoxemia and may predict
hospital mortality.5,6 Case 1 with elevated D-dimer, and Case 2 with
lymphopenia, elevated CRP and ESR, and biomarkers of cardiac injury
(elevated CKMB and troponin) died. However, Case 3 with a normal
lymphocyte count and CRP survived.
These cases raise the possibility that performing elective opera-
tive interventions on patients with undetected hidden or mild forms of
COVID-19 may lead to contamination of operative room and equip-
ment, with risk of transmission of the infection to operative team and
other healthcare providers in hospitals. Secondary transmission of
COVID-19 in the hospital setting is not uncommon.3 Case 3, who
developed fever on postoperative day 2, probably had hidden or mild
form of disease at the time of surgery with a real risk of spreading to
others during hospital admission. It is not clear if Case 1 and Case 2,
who were readmitted about 2 weeks after surgery, got the infection at
the time of surgery or after hospital discharge in the community, but we
do not yet know whether undergoing major surgery might reduce the
individual’s ability to fight this infection. Obviously if Case 4 was not
presenting with pulmonary manifestations (eg, if he was only in the
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incubation period of infection with minimal symptoms), hewould have
had the bariatric procedure the next day.
At the very least, COVID-19 can complicate the perioperative
course with diagnostic challenges and potentially increase the fatality
rate. As we learn more about this disease, likely depending on the
severity of an epidemic and availability of resources, the risk and
benefits of performing elective surgical procedures should be care-
fully re-assessed. In locations with widespread infections and limited
resources, the risk of elective surgical procedures for index patient
and community may outweigh the benefit, especially when one
considers the potential for unnecessary utilization of personal pro-
tective equipment (PPE). In some situations, postponing elective
surgical procedures might be the right decision, although it depends
on how the word ‘‘elective’’ is defined, and many of our patients will
still need treatment as an emergency, for cancer, or for symptomatic
conditions that may deteriorate over time.
Our response to and management of this situation will evolve
over time. Many institutions are currently dealing with critical,
hopefully short-term, limitations of PPE availability. In this period,
conservation will be all important. As time goes on and we become
more used to working in a COVID-19 environment, we will adjust
our workflows and decision making to optimize care for our patients,
while also caring for the caregivers. Many expert groups are currently
sending out recommendations for dealing with coronavirus, although
little evidence exists at the present time other than anecdotal reports.
What is clear is that we must protect our surgeons and caregiver and
address their fears, while balancing risk to others, to patients, and
managing the availability of resources. Concerns about aerosoliza-
tion in otolaryngology or skull base surgery, endoscopic, or laparo-
scopic procedures are being discussed, and this may become more of
a concern as the prevalence of asymptomatic or undetected cases
increases, and as hospitals get back to doing ‘‘elective’’ surgery.
While point of care testing or preoperative chest CT scan may also
help us address this, the accuracy of testing asymptomatic patients is
not clear. For peri-operative care, using telemedicine and virtual
visits using a smartphone or other devices can also be an option to
decrease the risk of spreading infection during the outbreaks.
In conclusion, although many questions remain unanswered
about COVID-19 and surgical practice, the surgical and perioperative
communities should be aware that this virus may impact peri-
operative outcomes, as well as caregiver practice. Careful delibera-
tion and rapid studies to determine the correct response will be
critical as we proceed into the future.
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FIGURE 1. Chest CT scan of COVID-19 pneumonia. A, Case 1:
Bilateral large areas of ground-glass opacities and consolida-
tions, giving a white lung appearance, 19 d after an elective
incisional hernia repair. B, Case 2: Unilateral peripheral ground-
glass opacities 16 d after laparoscopic cholecystectomy. C, Case
3: Bilateral dependent consolidations in lung bases with mini-
mal pleural effusion 3 d after hysterectomy and cholecystec-
tomy.
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